Lindbrook Capital LLC Has $72,000 Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Lindbrook Capital LLC raised its position in HealthEquity, Inc. (NASDAQ:HQY) by 27.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 750 shares of the company’s stock after acquiring an additional 162 shares during the period. Lindbrook Capital LLC’s holdings in HealthEquity were worth $72,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI acquired a new position in HealthEquity in the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC raised its holdings in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $39,000. UMB Bank n.a. raised its holdings in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares in the last quarter. Finally, First Horizon Advisors Inc. raised its holdings in shares of HealthEquity by 50.7% in the 4th quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock worth $107,000 after buying an additional 375 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Down 0.7 %

NASDAQ HQY opened at $100.58 on Friday. The firm has a market cap of $8.72 billion, a PE ratio of 92.28, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock’s 50 day simple moving average is $105.80 and its 200 day simple moving average is $94.52. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the business earned $0.40 earnings per share. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Mizuho assumed coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Raymond James increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Finally, JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $113.54.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 39,000 shares of company stock worth $3,895,788. Insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.